Back to Browse Journals » Clinical Interventions in Aging » Volume 2 » Issue 4

Testosterone replacement therapy for older men

Authors Stephen E Borst, Thomas Mulligan

Published Date January 2007 Volume 2007:2(4) Pages 561—566

DOI http://dx.doi.org/10.2147/CIA.S1609

Published 3 January 2007

Stephen E Borst, Thomas Mulligan

Geriatrics Research, Education, and Clinical Center, North Florida/South Georgia Veterans Health System, Gainesville, FL, USA

Abstract: Despite intensive research on testosterone therapy for older men, important questions remain unanswered. The evidence clearly indicates that many older men display a partial androgen deficiency. In older men, low circulating testosterone is correlated with low muscle strength, with high adiposity, with insulin resistance and with poor cognitive performance. Testosterone replacement in older men has produced benefits, but not consistently so. The inconsistency may arise from differences in the dose and duration of testosterone treatment, as well as selection of the target population. Generally, studies reporting anabolic responses to testosterone have employed higher doses of testosterone for longer treatment periods and have targeted older men whose baseline circulating bioavailable testosterone levels were low. Most studies of testosterone replacement have reported anabolic that are modest compared to what can be achieved with resistance exercise training. However, several strategies currently under evaluation have the potential to produce greater anabolic effects and to do so in a safe manner. At this time, testosterone therapy can not be recommended for the general population of older men. Older men who are hypogonadal are at greater risk for the catabolic effects associated with a number of acute and chronic medical conditions. Future research is likely to reveal benefits of testosterone therapy for some of these special populations. Testosterone therapy produces a number of adverse effects, including worsening of sleep apnea, gynecomastia, polycythemia and elevation of PSA. Efficacy and adverse effects should be assessed frequently throughout the course of therapy.
Keywords: aging, testosterone, hypogonadism, physical function

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery

Vasconcelos A, Vega E, Pérez Y, Gómara MJ, García ML, Haro I

International Journal of Nanomedicine 2015, 10:609-631

Published Date: 27 January 2015

Safety and efficacy of testosterone gel in the treatment of male hypogonadism

Kishore M Lakshman, Shehzad Basaria

Clinical Interventions in Aging 2009, 4:397-412

Published Date: 9 October 2009

Use of short-acting insulin aspart in managing older people with diabetes

Eltayeb Marouf, Alan J Sinclair

Clinical Interventions in Aging 2009, 4:187-190

Published Date: 17 April 2009

Valuing the person’s story: Use of life story books in a continuing care setting

Teresa Wills, Mary Rose Day

Clinical Interventions in Aging 2008, 3:547-552

Published Date: 2 October 2008

Zoster vaccine live for the prevention of shingles in the elderly patient

Jamie Zussman, Lorraine Young

Clinical Interventions in Aging 2008, 3:241-250

Published Date: 30 June 2008

Update on bazedoxifene: A novel selective estrogen receptor modulator

Diane M Biskobing

Clinical Interventions in Aging 2007, 2:299-303

Published Date: 8 October 2007

A gero-informatics tool to enhance the care of hospitalized older adults with cognitive impairment

Malaz Boustani, Stephanie Munger, Robin Beck, Noll Campbell, Michael Weiner

Clinical Interventions in Aging 2007, 2:247-253

Published Date: 14 August 2007

Treating senile dementia with traditional Chinese medicine

Han Yan, Lin Li, Xi Can Tang

Clinical Interventions in Aging 2007, 2:201-208

Published Date: 14 August 2007

Teriparatide in the management of osteoporosis

Donald Bodenner, Carolyn Redman, Ann Riggs

Clinical Interventions in Aging 2007, 2:499-507

Published Date: 3 January 2007